Mitchell E. Horwitz

7.7k total citations · 2 hit papers
144 papers, 3.8k citations indexed

About

Mitchell E. Horwitz is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Mitchell E. Horwitz has authored 144 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Hematology, 45 papers in Oncology and 37 papers in Genetics. Recurrent topics in Mitchell E. Horwitz's work include Hematopoietic Stem Cell Transplantation (95 papers), Polyomavirus and related diseases (27 papers) and Mesenchymal stem cell research (26 papers). Mitchell E. Horwitz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (95 papers), Polyomavirus and related diseases (27 papers) and Mesenchymal stem cell research (26 papers). Mitchell E. Horwitz collaborates with scholars based in United States, Spain and Netherlands. Mitchell E. Horwitz's co-authors include Keith M. Sullivan, David A. Rizzieri, Nelson J. Chao, Richard T. Maziarz, Harry L. Malech, Gwynn D. Long, Steven M. Holland, Patrick J. Stiff, Cristina Gasparetto and Auayporn Nademanee and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mitchell E. Horwitz

135 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

2009 579 citations Patrick J. Stiff, Richard T. Maziarz et al. Blood profile →
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

2017 400 citations Brent R. Logan, Steven M. Devine et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mitchell E. Horwitz	2.5k	1.3k	947	726	526	144	3.8k
Yoshihisa Kodera	2.6k 1.0×	1.8k 1.4×	865 0.9×	584 0.8×	664 1.3×	143	4.1k
Florent Malard	2.1k 0.9×	946 0.7×	1.1k 1.2×	1.0k 1.4×	643 1.2×	145	3.6k
Yoichi Takaue	2.1k 0.9×	1.2k 0.9×	1.3k 1.4×	551 0.8×	528 1.0×	218	4.1k
Voravit Ratanatharathorn	2.0k 0.8×	1.1k 0.8×	857 0.9×	350 0.5×	432 0.8×	140	3.6k
Dirk Schwabe	1.2k 0.5×	1.4k 1.0×	1.2k 1.3×	683 0.9×	633 1.2×	105	3.7k
Paul V. O’Donnell	2.6k 1.1×	1.7k 1.3×	1.3k 1.4×	541 0.7×	738 1.4×	121	4.4k
Hérvè Chambost	2.2k 0.9×	941 0.7×	600 0.6×	749 1.0×	346 0.7×	134	3.8k
Marco Mielcarek	4.0k 1.6×	1.9k 1.4×	1.1k 1.2×	536 0.7×	997 1.9×	117	5.3k
Bimalangshu R. Dey	1.5k 0.6×	1.2k 0.9×	927 1.0×	435 0.6×	373 0.7×	79	3.4k
Cindy Ippoliti	2.9k 1.2×	1.3k 1.0×	1.2k 1.3×	366 0.5×	719 1.4×	81	4.4k

Countries citing papers authored by Mitchell E. Horwitz

Since Specialization

Citations

This map shows the geographic impact of Mitchell E. Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Horwitz more than expected).

Fields of papers citing papers by Mitchell E. Horwitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell E. Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Horwitz. The network helps show where Mitchell E. Horwitz may publish in the future.

Co-authorship network of co-authors of Mitchell E. Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell E. Horwitz. A scholar is included among the top collaborators of Mitchell E. Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell E. Horwitz. Mitchell E. Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horwitz, Mitchell E., Gary J. Schiller, Sang‐Bing Tsai, et al.. (2025). Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program. Transplantation and Cellular Therapy. 31(7). 436–447.

Carlsen, Eric D., et al.. (2024). Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report. SHILAP Revista de lepidopterología. 2024(1). 6526961–6526961.

Eapen, Mary, Joseph H. Antin, Jakub Tolar, et al.. (2024). Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study. EClinicalMedicine. 76. 102819–102819. 3 indexed citations

Ho, Vincent T., Thomas R. Klumpp, Mitchell E. Horwitz, et al.. (2023). Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability. Transplantation and Cellular Therapy. 29(9). 539–547. 1 indexed citations

Hussaini, S. M. Qasim, Yi Ren, Alessandro Racioppi, et al.. (2023). Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis. JCO Oncology Practice. 20(3). 351–360. 8 indexed citations

Rodríguez‐Arbolí, Eduardo, Catherine J. Lee, Teresa Caballero‐Velázquez, et al.. (2023). Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials. Clinical Cancer Research. 29(20). 4057–4067. 3 indexed citations

Szabolcs, Paul, Roei David Mazor, Dima Yackoubov, et al.. (2023). Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Transplantation and Cellular Therapy. 29(8). 517.e1–517.e12. 6 indexed citations

Hussaini, S. M. Qasim, Yi Ren, Alessandro Racioppi, et al.. (2023). Financial toxicity and quality of life in patients undergoing bone marrow transplant evaluation: A single center analysis.. Journal of Clinical Oncology. 41(16_suppl). 7052–7052. 1 indexed citations

Horwitz, Mitchell E., Sang‐Bing Tsai, Andrew R. Rezvani, et al.. (2023). Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program. Blood. 142(Supplement 1). 6894–6894.

10.

Horwitz, Mitchell E., Patrick J. Stiff, Corey Cutler, et al.. (2022). Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplant with Omidubicel Demonstrates Sustained Clinical Improvement Versus Standard Myeloablative Umbilical Cord Blood Transplantation (UCBT): Final Results of a Phase III Randomized, Multicenter Study. Transplantation and Cellular Therapy. 28(3). S73–S74. 1 indexed citations

11.

Lin, Chenyu, Gautam Sajeev, Patrick J. Stiff, et al.. (2022). Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy. 29(1). 52.e1–52.e9. 3 indexed citations

12.

Koning, Coco de, Weiyang Tao, Mitchell E. Horwitz, et al.. (2021). Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation. Bone Marrow Transplantation. 56(11). 2826–2833. 3 indexed citations

13.

Fuchs, Ephraim J., Paul V. O’Donnell, Mary Eapen, et al.. (2020). Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137(3). 420–428. 106 indexed citations

14.

Ramalingam, Sendhilnathan, Mohammad Rauf Chaudhry, Yi Ren, et al.. (2020). Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLoS ONE. 15(9). e0238824–e0238824. 4 indexed citations

15.

Saullo, Jennifer L., Yanhong Li, Julia A. Messina, et al.. (2019). Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy. Biology of Blood and Marrow Transplantation. 26(3). 568–580. 8 indexed citations

16.

Anand, Sarah, Samantha M. Thomas, Terry Hyslop, et al.. (2017). Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization. Biology of Blood and Marrow Transplantation. 23(7). 1151–1157. 27 indexed citations

17.

Horwitz, Mitchell E., G D Long, Cristina Gasparetto, et al.. (2010). Plerixafor Given “Just In Time” For Peripheral Blood Stem Cell Mobilization Of Patients With Suboptimal Response To G-CSF. Biology of Blood and Marrow Transplantation. 16(2). S208–S208. 1 indexed citations

18.

Rizzieri, David A., Robert W. Storms, Dongfeng Chen, et al.. (2010). Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(8). 1107–1114. 65 indexed citations

19.

Bolan, Charles D., Yu Ying Yau, Mitchell E. Horwitz, et al.. (2004). Pediatric large‐volume leukapheresis: a single institution experience with heparin versus citrate‐based anticoagulant regimens. Transfusion. 44(2). 229–238. 36 indexed citations

20.

Horwitz, Mitchell E., et al.. (1999). Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA. Experimental Hematology. 27(7). 1160–1167. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact